David M. Epstein - Aug 14, 2024 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GYRE	Stock Option (Right to Buy)	Award	$0	+52K		$0.00	52K	Aug 14, 2024	Common Stock	52K	$9.98	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option represents a right to purchase a total of 52,000 shares of the Issuer's common stock, which will vest in 36 equal monthly installments through August 14, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.